NDAINHALATIONAEROSOL, METERED
Approved
Nov 1967
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BRONITIN MIST (epinephrine bitartrate) by Pfizer is 12. Approved for regional anesthesia, analgesia for surgery, dental and 4 more indications. First approved in 1967.
Drug data last refreshed 13h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BRONITIN MIST is an inhaled metered aerosol formulation of epinephrine bitartrate, a sympathomimetic vasopressor and bronchodilator. It is indicated for emergency relief of bronchospasm and acute respiratory distress. The drug works by stimulating alpha and beta-adrenergic receptors to produce rapid airway relaxation and improved breathing.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30% intensity), signaling potential team consolidation and transition focus toward legacy brand management or portfolio wind-down activities.
Mechanism of Action
12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the…
Worked on BRONITIN MIST at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.